AhR inhibition promotes axon regeneration via a stress–growth switch
Summary
This Nature paper shows that the aryl hydrocarbon receptor (AhR) — a ligand-activated bHLH-PAS transcription factor best known for sensing xenobiotics — acts as a neuron-intrinsic brake on axon regrowth after injury. Genetic deletion or pharmacological inhibition of neuronal AhR boosts axon elongation in peripheral nerve and spinal cord injury models. Mechanistically, AhR activation engages proteostasis and integrated stress responses that suppress translation; AhR loss lifts that brake, increasing mTOR signalling, protein synthesis and HIF1α–ARNT-driven pro-growth programmes. The authors position AhR as a central regulator of a stress–growth switch with therapeutic implications for neural repair.
Key Points
- DRG neurons are responsive to AhR ligands; nuclear AhR increases after a peripheral conditioning lesion.
- Neuronal Ahr knockdown or inducible Ahr conditional knockout (cKO) markedly increases neurite outgrowth in vitro and accelerates regeneration in vivo after sciatic nerve crush and spinal cord contusion.
- AhR activation drives a transcriptional regulon enforcing proteostasis and the integrated stress response (ISR); AhR loss shifts the injury programme toward translation, metabolism and growth signalling.
- Ahr cKO neurons show ~25% higher de novo protein synthesis (puromycin assay), elevated p-RPS6 and reduced p-eIF2α, consistent with release from translational suppression.
- Cross-talk with HIF1α and shared dimer partner ARNT is necessary for the growth advantage; HIF1α inhibition or Arnt knockdown abolishes the Ahr-cKO benefit.
- Pharmacological AhR antagonists (SR1, BAY, TMF) can phenocopy aspects of the genetic deletion, but timing and compound pharmacokinetics matter; early priming is required for maximal effect.
- Gut microbiome depletion did not blunt the phenotype, suggesting local or non-microbial ligand sources and a neuron-intrinsic mechanism dominate in these models.
- Integration with epigenomic data links AhR/HIF1α programmes to 5hmC changes and BMAL1-dependent gating of regenerative responses.
Content summary
Using transcriptomics, pharmacology, siRNA, inducible neuronal Ahr cKO mice and injury models (sciatic nerve lesion and thoracic spinal cord contusion), the authors demonstrate that AhR is rapidly induced after peripheral axotomy and that its activity enforces stress-adaptive programmes that constrain regeneration. Loss of neuronal AhR increases neurite length in mouse and human neurons in vitro and enhances axon extension and functional recovery in vivo. RNA-seq and ChEA3 analyses identify an AhR-dependent regulon enriched for xenobiotic metabolism, RNA Pol III and translational control, autophagy, mitochondrial–cytosolic cross-talk and ISR components (ATF4, ATF6, XBP1). Functional assays confirm increased global protein synthesis and elevated mTOR readouts in Ahr-deficient neurons. Cross-talk experiments show that the regenerative gain depends on HIF1α–ARNT signalling, while epigenomic overlap with injury-induced 5hmC sites ties AhR activity into broader transcriptional and epigenetic reprogramming after axotomy.
Context and relevance
Axon regeneration in the adult mammalian CNS is limited; understanding intrinsic neuronal switches that favour stress adaptation over growth is critical. This study identifies AhR — conventionally studied in toxicology and barrier immunity — as a key mediator that diverts injured neurons toward proteostasis and translational suppression at the expense of regeneration. The findings connect metabolic/epigenetic regulators (HIF1α, BMAL1, 5hmC) with a ligand-sensitive transcriptional brake that can be targeted pharmacologically, offering a potentially new axis for enhancing repair after peripheral nerve injury and spinal cord damage.
Why should I read this?
Because if you work on nerve repair, neurotrauma or regenerative therapeutics, this paper hands you a neat mechanistic switch to think about: block AhR and neurons favour growth over hunkering down into stress mode. It’s got genetic, pharmacological and functional data across PNS and CNS injury models — worth a quick skim if you want a new target to test or a fresh angle on how translation and stress responses gate regeneration.
Author style
Punchy: the work argues strongly that AhR is a central, druggable brake on regeneration — if you care about translating molecular insights into repair strategies, read the full paper for the experimental details and caveats (timing, ligand identity, drug specificity and safety).